文献速递支持与姑息治疗

美国青少年和青年癌症患者的生存趋势:与儿童和老年人的比较

Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults.
PubMed 文献 · J Clin Oncol · 2023-10-26

该分析基于美国国家癌症研究所监测、流行病学和最终结果项目17个登记区的数据,更新了2010-2018年青少年和青年(15-39岁)按癌种、分期、性别和种族/民族分层的5年相对生存率,并计算了2000-2014年生存趋势,与儿童和老年人进行比较。结果显示青少年和青年与儿童的5年相对生存率均为86%,生存改善幅度相似(平均绝对变化:青少年和青年0.33%,儿童0.36%),但部分癌种生存较差或下降,且男性和非西班牙裔黑人/非洲裔美国青少年和青年生存更差。

要点

  • 青少年和青年与儿童的5年相对生存率均为86%,2000年以来73%的癌种生存改善。
  • 骨肉瘤和男性乳腺癌生存无改善,宫颈癌和女性膀胱癌生存下降。
  • 除卡波西肉瘤和膀胱癌外,男性生存均劣于女性;非西班牙裔黑人/非洲裔美国青少年和青年在多癌种生存更差。

核心结论

  • 未来研究应关注影响年龄、性别和种族/民族生存差异的因素。
  • 生物学差异、临床试验入组、按临床指南实施治疗以及支持和长期生存照护可能解释观察到的生存差异,值得进一步研究。

研究设计与样本

  • 研究获取美国国家癌症研究所监测、流行病学和最终结果项目17个登记区的数据,按癌种、分期、性别和种族/民族分层,年龄组包括青少年和青年(15-39岁)、儿童和老年人。
  • 研究计算了2010-2018年5年相对生存率估计值,并计算了2000-2014年5年相对生存趋势。

主要发现

  • 在33种常见青少年和青年癌症中,青少年和青年与儿童的5年相对生存率均为86%,生存改善幅度相似(平均绝对变化:青少年和青年0.33%,儿童0.36%)。
  • 青少年和青年中73%的癌症自2000年以来5年相对生存率有改善。
  • 研究识别出青少年和青年生存劣于更年轻或更年长患者的癌症,以及生存无改善(骨肉瘤和男性乳腺癌)或下降(宫颈癌和女性膀胱癌)的癌症。
  • 除卡波西肉瘤和膀胱癌外,男性所有癌症的生存均劣于女性。
  • 非西班牙裔黑人/非洲裔美国青少年和青年在本研究考虑的许多癌症中生存劣于其他种族/民族组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although data from 1975 to 1997 revealed a gap in cancer survival improvement in adolescents and young adults (AYAs; 15-39 years) compared with children and older adults, more recent studies have reported improvements in AYA cancer survival overall. The current analysis provides an update of 5-year relative survival and cancer survival trends among AYAs compared with children and older adults. METHODS: We obtained data from the National Cancer Institute Surveillance, Epidemiology, and End Results Program for 17 regions to obtain recent (2010-2018) 5-year relative survival estimates by cancer type, stage, sex, and race/ethnicity by age group. In addition, we calculated 5-year relative survival trends during 2000-2014. RESULTS: Across 33 common AYA cancers, AYAs and children had high 5-year relative survival (86%) and experienced similar survival improvements over time (average absolute change: AYAs, 0.33%; children 0.36%). Among AYAs, 73% of cancers had improvement in 5-year relative survival since 2000. Despite this overall progress, we identified cancers where survival was worse in AYAs than younger or older patients and cancers that have had either a lack of improvement (osteosarcoma and male breast) or decreases in survival (cervical and female bladder) over time. Furthermore, males had inferior survival to females for all cancers, except Kaposi sarcoma and bladder cancer, and non-Hispanic Black/African American AYAs experienced worse survival than other racial/ethnic groups for many cancers considered in this study. CONCLUSION: Future studies should focus on identifying factors affecting survival disparities by age, sex, and race/ethnicity. Differences in biology, clinical trial enrollment, delivery of treatment according to clinical guidelines, and supportive and long-term survivorship care may account for the survival disparities we observed and warrant further investigation.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Keegan THM, Abrahão R, Alvarez EM, et al. Survival Trends Among Adolescents and Young Adults Diagnosed With Cancer in the United States: Comparisons With Children and Older Adults. J Clin Oncol. 2023. PMID: 37883740. doi:10.1200/JCO.23.01367

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。